Skip to main content
. 2018 Nov 21;26(7):1181–1194. doi: 10.1038/s41418-018-0231-3

Table 1.

Aberrant splicing isoforms in cancer and its clinical application

Isoform A Function Cancer type Splicing type Refs
Isoform B
Proliferation cyclin D1 Tumour suppressor gene Prostate tumours Intron retention [21]
cyclin D1b Associate with progression
Syk Tumour suppressor Breast tumours Exon skipping [26]
Syk(S) Mammary tumour progression
RASSF5 Tumourigenesis Oesophageal cancer Promoter usage [25]
RASSF5A Tumour suppressor
WT1 Proliferation Breast cancer Exon skipping [27, 100]
WT1iso Development & progression
Metastasis CD44 Drive metastasis Breast cancer Addition of amino acids [30]
CD44V6 Pro-metastatic molecule
CrkII Migration Glioblastoma Exon skipping [101]
CrkI Promote cell migration
KLF6 Tumour suppressor gene Lung cancer 5′- SS [34]
KLF6-SV1 Driver of tumour metastasis
VEGFA Metastasis Sarcoma Exon 8 [35]
VEGFA iso Advantage for metastasis
Apoptosis BCL-Xs Pro-apoptosis Many cancer types 5′-SS [75]
BCL-XL Anti-apoptosis
nCLu Pro-apoptotic Many cancer types Frame shift [41]
sCLu Pro-survival
ELF2A Pro-apoptosis Cancer cell lines 5′-SS [42]
ELF2B Anti-apoptosis
RIP3 Pro-apoptosis Colon & lung cancer Intron retention [43]
RIP3γ Anti-apoptosis
Drug resistance AR Chemosensitivity Prostate cancer Exon skipping [70]
AR-v7 Chemoresistance
BRCA1 Repair of DNA break Breast cancer Exon skipping [49]
BRCA1Δ11 Chemoresistance
c-FLIP(L) Anti-apoptosis Pancreatic cancer Truncated C-terminus [50]
c-FLIP(S) Drug resistance
Survivin Anti-apoptosis Neoplastc cells Intron retention [48]
Survivin 3B Promote chemoresistance
Radiotherapy sCLu Genomic instability Breast cancer cells 5′-SS [53]
nCLu Pro-death factor
Mcl-1L Anti-apoptotic OSCC Exon skipping [54]
Mcl-1S Pro-apoptotic
NPM1 Radioresistance Cervical cancer Intron retention [55]
NPM2 Radiosensitivity
Tap73 Pro-apoptosis Cervical cancer Exon skipping [60]
ΔNp73 Anti-apoptosis